Related Experiment Video
Updated: Nov 11, 2025
05:31
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
1.0K
Extracellular Vesicles and Preeclampsia: Current Knowledge and Future Research Directions
Carlos Palma1, Jessica Jellins2, Andrew Lai1
1Faculty of Health Sciences, Exosome Biology Laboratory, Centre for Clinical Diagnostics, University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, Australia.
Sub-Cellular Biochemistry
|March 29, 2021
Summary
Preeclampsia (PE) involves placental extracellular vesicles (EVs) that communicate between mother and fetus. These EVs may serve as biomarkers and therapeutic targets for managing PE complications.
Area of Science:
- Obstetrics and Gynecology
- Cell Biology
- Biochemistry
Background:
- Preeclampsia (PE) leads to severe maternal and offspring long-term health issues.
- Proper materno-fetal exchange relies on placental perfusion and vascular tree development.
- Placenta-derived extracellular vesicles (EVs) are key in intercellular communication, impacting placental and endothelial cell function.
Purpose of the Study:
- To review the role of placenta-derived EVs in preeclampsia.
- To explore EVs as potential biomarkers and therapeutic delivery tools for PE.
- To discuss EV biogenesis, specificity, and characterization in PE pregnancies.
Main Methods:
- Literature review focusing on placenta-derived EVs in PE.
- Analysis of studies on EV content and function in normal and PE pregnancies.
- Discussion of methods for EV characterization relevant to PE.
Main Results:
- EVs from the placenta carry bioactive molecules and specific proteins/miRNAs.
- EV concentration and content in maternal plasma may correlate with PE severity.
- Placenta-derived EVs can be distinguished from maternal EVs.
Conclusions:
- Placenta-derived EVs play a significant role in PE pathophysiology.
- EVs hold promise as diagnostic biomarkers and therapeutic agents for PE.
- Further research into EV biogenesis and characterization is crucial for clinical application.
